241 related articles for article (PubMed ID: 27405061)
21. Risk factors for mortality in septic patients who received etomidate.
Rech MA; Bennett S; Chaney W; Sterk E
Am J Emerg Med; 2015 Oct; 33(10):1340-3. PubMed ID: 26321168
[TBL] [Abstract][Full Text] [Related]
22. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
Buckley MS; MacLaren R
J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
[TBL] [Abstract][Full Text] [Related]
23. Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial.
Tilouche N; Jaoued O; Ali HBS; Gharbi R; Fekih Hassen M; Elatrous S
Shock; 2019 Nov; 52(5):481-486. PubMed ID: 30628950
[TBL] [Abstract][Full Text] [Related]
24. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
25. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
[TBL] [Abstract][Full Text] [Related]
27. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.
Katsenos CS; Antonopoulou AN; Apostolidou EN; Ioakeimidou A; Kalpakou GT; Papanikolaou MN; Pistiki AC; Mpalla MC; Paraschos MD; Patrani MA; Pratikaki ME; Retsas TA; Savva AA; Vassiliagkou SD; Lekkou AA; Dimopoulou I; Routsi C; Mandragos KE;
Crit Care Med; 2014 Jul; 42(7):1651-7. PubMed ID: 24674923
[TBL] [Abstract][Full Text] [Related]
28. Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis.
Jung B; Clavieras N; Nougaret S; Molinari N; Roquilly A; Cisse M; Carr J; Chanques G; Asehnoune K; Jaber S
Crit Care; 2012 Nov; 16(6):R224. PubMed ID: 23171852
[TBL] [Abstract][Full Text] [Related]
29. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
[TBL] [Abstract][Full Text] [Related]
30. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
31. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
33. Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan.
Fujii T; Udy AA; Deane AM; Luethi N; Bailey M; Eastwood GM; Frei D; French C; Orford N; Shehabi Y; Young PJ; Bellomo R;
Crit Care Resusc; 2019 Jun; 21(2):119-125. PubMed ID: 31142242
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Initiation Timing of Hydrocortisone in Adult Patients With Septic Shock.
Sacha GL; Chen AY; Palm NM; Duggal A
Shock; 2021 Apr; 55(4):488-494. PubMed ID: 32890314
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
36. Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial.
O'Hearn K; McNally D; Choong K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Menon K;
Trials; 2016 May; 17(1):238. PubMed ID: 27153945
[TBL] [Abstract][Full Text] [Related]
37. A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study.
Menon K; McNally D; O'Hearn K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Choong K;
Pediatr Crit Care Med; 2017 Jun; 18(6):505-512. PubMed ID: 28406862
[TBL] [Abstract][Full Text] [Related]
38. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
Valoor HT; Singhi S; Jayashree M
Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
[TBL] [Abstract][Full Text] [Related]
39. Abrupt Discontinuation Versus Taper of Hydrocortisone in Patients With Septic Shock.
Carabetta S; Allen B; Cannon C; Johnson T
Ann Pharmacother; 2023 Apr; 57(4):375-381. PubMed ID: 35927963
[TBL] [Abstract][Full Text] [Related]
40. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.
Oppert M; Reinicke A; Gräf KJ; Barckow D; Frei U; Eckardt KU
Intensive Care Med; 2000 Dec; 26(12):1747-55. PubMed ID: 11271081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
